arrow
D

Daniel A. Erlanson

University of California San Francisco
H指数:32
被引数:6,152

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesity

CT-388(一种每周一次的选择性GLP-1/GIP受体激动剂)对预临床模型和肥胖受试者中体重减轻及血糖控制的效应

2025-11-280
OAAI
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitors
2021-08-018
PREAI
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C
2019-08-2089
OAAI
Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens
2019-07-0114
PREAI